Zhejiang Expressway $860 million rights issue
The H shares are listed on the Hong Kong Stock Exchange
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Innovent Biologics HK$2.4 billion placement of shares
The shares are listed on the Hong Kong Stock Exchange
CStone Pharmaceuticals HK$392.9 million placing of new shares
We advised CStone Pharmaceuticals on the placement
New Horizon Health HK$781.7 million top-up placement of shares
We advised New Horizon Health on the top-up placement
Jinxin Fertility Group HK$1.17 billion top-up placement of shares
The shares are listed on the Hong Kong Stock Exchange
Tencent Music Entertainment Group secondary listing
We advised Tencent Music Entertainment Group on its secondary listing by way of introduction on the HKEX
Akeso HK$582 million share placement
We advised Akeso in the placement of new shares
Li Auto $2 billion at-the-market offering
This is the first at-the-market offering by a U.S.-listed issuer with a dual primary listing in Hong Kong
Zai Lab $857.5 million offering of American depositary shares and ordinary shares
We advised Zai Lab on the concurrent offerings
InnoCare Pharma HK$3.04 billion share placement
We advised InnoCare Pharma in the placement of new shares